In bladder cancer, MAGI2-AS3 operates through a ceRNA mechanism involving the MAGI2-AS3/miR-31–5p/TNS1 axis, with its downregulation linked to increased migration, proliferation, and invasion, emphasizing its role in metastasis and tumor staging (Table 1) (80). Here, PDS5B is linked to urinary bladder cancer.